Glenn J. Bubley

Active 1990–2024

61: Papers
19,095: Citations
54: h-index
61: i10-index

Citations

Citation sources

Countries

0%33.5%Other 21%

Institutions

Fields

Topics

All papers

Sort

The Molecular Taxonomy of Primary Prostate Cancer
Authors: Adam Abeshouse, Jaeil Ahn, Rehan Akbani, Adrian Ally, Samirkumar B. Amin, Chris Andry, Matti Annala, Armen Aprikian, Joshua Armenia, Arshi Arora, J. Todd Auman, Miruna Balasundaram, Saianand Balu, Christopher E. Barbieri, Thomas Bauer, Christopher C. Benz, Alain Bergeron, Rameen Beroukhim, Mario Berríos, Adrian Bivol, Tom Bodenheimer, Lori Boice, Moiz S. Bootwalla, Rodolfo Borges dos Reis, Paul C. Boutros, Jay Bowen, Reanne Bowlby, Jeffrey M. Boyd, Robert K. Bradley, Anne Breggia, Fadi Brimo, Christopher A. Bristow, Denise Brooks, Bradley M. Broom, Alan H. Bryce, Glenn J. Bubley, Eric Burks, Yaron S.N. Butterfield, M. Button, David Canes, Carlos Gilberto Carlotti, Rebecca Carlsen, Michel Carmel, Peter R. Carroll, Scott L. Carter, Richard W. Cartun, Brett S. Carver, June M. Chan, Matthew T. Chang, Yu Chen, Andrew D. Cherniack, Simone Chevalier, Lynda Chin, Juok Cho, Andy Chu, Eric Chuah, Sudha Chudamani, Kristian Cibulskis, Giovanni Ciriello, Amanda Clarke, Matthew R. Cooperberg, Niall M. Corcoran, Anthony J. Costello, Janet E. Cowan, Daniel Crain, Erin Curley, Kerstin A. David, John A. Demchok, Francesca Demichelis, Noreen Dhalla, Rajiv Dhir, Alexandre A. Doueik, Bettina F. Drake, Heidi Dvinge, Natalya Dyakova, Ina Felau, Martin L. Ferguson, Scott Frazer, Stephen J. Freedland, Yao Fu, Stacey Gabriel, Jianjiong Gao, Johanna Gardner, Julie M. Gastier-Foster, Nils Gehlenborg, Mark Gerken, Mark Gerstein, Gad Getz, Andrew K. Godwin, Anuradha Gopalan, Markus Graefen, Kiley Graim, Thomas Gribbin, Ranabir Guin, Manaswi Gupta, Angela Hadjipanayis, Syed Haider, Lucie Hamel, D. Neil Hayes, David I. Heiman and 212 more - Cell 2015 cited by 3,279
Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group
Authors: Howard I. Scher, Susan Halabi, Ian F. Tannock, Michael J. Morris, Cora N. Sternberg, Michael A. Carducci, Mario A. Eisenberger, Celestia S. Higano, Glenn J. Bubley, Robert Dreicer, Daniel Petrylak, Philip W. Kantoff, Ethan Basch, William Kevin Kelly, William D. Figg, Eric J. Small, Tomasz M. Beer, George Wilding, Alison Martin, Maha Hussain - Journal of Clinical Oncology 2008 cited by 2,241
Biology of Prostate-Specific Antigen
Authors: Steven P. Balk, Yoo-Joung Ko, Glenn J. Bubley - Journal of Clinical Oncology 2003 cited by 714
Results of a multicenter, phase 2 study of nivolumab and ipilimumab for patients with advanced rare genitourinary malignancies
Authors: Bradley A. McGregor, Matthew T. Campbell, Wanling Xie, Subrina Farah, Mehmet Asım Bilen, Andrew Schmidt, Guru Sonpavde, Kerry L. Kilbridge, Atish D. Choudhury, Amir Mortazavi, Amishi Y. Shah, Aradhana M. Venkatesan, Glenn J. Bubley, Arlene O. Siefker‐Radtke, Rana R. McKay, Toni K. Choueiri - Cancer 2020 cited by 112
Increased Expression of Genes Converting Adrenal Androgens to Testosterone in Androgen-Independent Prostate Cancer
Authors: Michael Stanbrough, Glenn J. Bubley, Kenneth N. Ross, Todd R. Golub, Mark A. Rubin, T.M. Penning, Phillip G. Febbo, Steven P. Balk - Cancer Research 2006 cited by 1,076
Mutation of the Androgen-Receptor Gene in Metastatic Androgen-Independent Prostate Cancer
Authors: Mary‐Ellen Taplin, Glenn J. Bubley, Todd D. Shuster, Martha E. Frantz, Amy E. Spooner, George K. Ogata, Harold Keer, Steven P. Balk - New England Journal of Medicine 1995 cited by 1,253
Evaluation of Intense Androgen Deprivation Before Prostatectomy: A Randomized Phase II Trial of Enzalutamide and Leuprolide With or Without Abiraterone
Authors: Rana R. McKay, Huihui Ye, Wanling Xie, Rosina T. Lis, Carla Calagua, Zhenwei Zhang, Quoc‐Dien Trinh, Steven L. Chang, Lauren C. Harshman, Ashley E. Ross, Kenneth J. Pienta, Daniel W. Lin, William J. Ellis, Bruce Montgomery, Peter Chang, Andrew A. Wagner, Glenn J. Bubley, Adam S. Kibel, Mary-Ellen Taplin - Journal of Clinical Oncology 2019 cited by 165
Prospective Evaluation of Clinical Outcomes Using a Multiplex Liquid Biopsy Targeting Diverse Resistance Mechanisms in Metastatic Prostate Cancer
Authors: Jamie M. Sperger, Hamid Emamekhoo, Rana R. McKay, Charlotte N. Stahlfeld, Anupama Singh, Xinyi E. Chen, Lucia Kwak, Cole S. Gilsdorf, Serena K. Wolfe, Xiao X. Wei, Rebecca Silver, Zhenwei Zhang, Michael J. Morris, Glenn J. Bubley, Felix Y. Feng, Howard I. Scher, Dana E. Rathkopf, Scott M. Dehm, Toni K. Choueiri, Susan Halabi, Andrew J. Armstrong, Alexander W. Wyatt, Mary‐Ellen Taplin, Shuang G. Zhao, Joshua M. Lang - Journal of Clinical Oncology 2021 cited by 61
Intense Androgen-Deprivation Therapy With Abiraterone Acetate Plus Leuprolide Acetate in Patients With Localized High-Risk Prostate Cancer: Results of a Randomized Phase II Neoadjuvant Study
Authors: Mary-Ellen Taplin, Bruce Montgomery, Christopher J. Logothetis, Glenn J. Bubley, Jerome P. Richie, Bruce L. Dalkin, Martin G. Sanda, John W. Davis, Massimo Loda, Lawrence D. True, Patricia Troncoso, Huihui Ye, Rosina T. Lis, Brett T. Marck, Alvin M. Matsumoto, Steven P. Balk, Elahe A. Mostaghel, T.M. Penning, Peter S. Nelson, Wanling Xie, Zhenyang Jiang, Christopher M. Haqq, Daniel Tamae, NamPhuong Tran, Weimin Peng, Thian Kheoh, Arturo Molina, Philip W. Kantoff - Journal of Clinical Oncology 2014 cited by 281
Neoadjuvant Enzalutamide Prior to Prostatectomy
Authors: Bruce Montgomery, Maria Tretiakova, Anthony M. Joshua, Martin Gleave, Neil Fleshner, Glenn J. Bubley, Elahe A. Mostaghel, Kim N., Daniel W. Lin, Martin G. Sanda, William Novotny, Kenneth K. Wu, Philip W. Kantoff, Brett T. Marck, Stephen R. Plymate, Steven P. Balk, Peter S. Nelson, Alvin M. Matsumoto, Rosina T. Lis, Adam S. Kibel, Gabriel P. Haas, Andrew Krivoshik, Alison L. Hannah, Mary‐Ellen Taplin - Clinical Cancer Research 2016 cited by 131
Neoadjuvant Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin With Pegfilgrastim Support in Muscle-Invasive Urothelial Cancer: Pathologic, Radiologic, and Biomarker Correlates
Authors: Toni K. Choueiri, Susanna Jacobus, Joaquim Bellmunt, Angela Qu, Leonard J. Appleman, Christopher Tretter, Glenn J. Bubley, Edward C. Stack, Sabina Signoretti, Meghara Walsh, Graeme S. Steele, Michelle S. Hirsch, Christopher J. Sweeney, Mary-Ellen Taplin, Adam S. Kibel, Katherine M. Krajewski, Philip W. Kantoff, Robert W. Ross, Jonathan E. Rosenberg - Journal of Clinical Oncology 2014 cited by 280
Randomized Trial of Olaparib With or Without Cediranib for Metastatic Castration-Resistant Prostate Cancer: The Results From National Cancer Institute 9984
Authors: Joseph W. Kim, Rana R. McKay, Marc R. Radke, Shilin Zhao, Mary‐Ellen Taplin, Nancy B. Davis, Paul Monk, Leonard J. Appleman, Primo N. Lara, Ulka N. Vaishampayan, Jingsong Zhang, Asit K. Paul, Glenn J. Bubley, Eliezer M. Van Allen, Serhan Ünlü, Ying Huang, Massimo Loda, Geoffrey I. Shapiro, Peter M. Glazer, Patricia LoRusso, S. Percy Ivy, Yu Shyr, Elizabeth M. Swisher, Daniel P. Petrylak - Journal of Clinical Oncology 2022 cited by 51
Expanded Prostate Cancer Index Composite for Clinical Practice: Development and Validation of a Practical Health Related Quality of Life Instrument for Use in the Routine Clinical Care of Patients With Prostate Cancer
Authors: Peter Chang, Konrad Szymañski, Rodney L. Dunn, Jonathan Chipman, Mark S. Litwin, Paul L. Nguyen, Christopher J. Sweeney, Robert L. Cook, Andrew A. Wagner, William C. DeWolf, Glenn J. Bubley, Renee Funches, Joseph A. Aronovitz, John T. Wei, Martin G. Sanda - The Journal of Urology 2011 cited by 194
Results of a Randomized Phase II Trial of Intense Androgen Deprivation Therapy prior to Radical Prostatectomy in Men with High-Risk Localized Prostate Cancer
Authors: Rana R. McKay, Wanling Xie, Huihui Ye, Fiona M. Fennessy, Zhenwei Zhang, Rosina T. Lis, Carla Calagua, Dana E. Rathkopf, Vincent P. Laudone, Glenn J. Bubley, David J. Einstein, Peter K. Chang, Andrew A. Wagner, J. Kellogg Parsons, Mark Preston, Kerry L. Kilbridge, Steven L. Chang, Atish D. Choudhury, Mark M. Pomerantz, Quoc‐Dien Trinh, Adam S. Kibel, Mary‐Ellen Taplin - The Journal of Urology 2021 cited by 77
Taxane resistance in prostate cancer is mediated by decreased drug-target engagement
Authors: Ada Gjyrezi, Fang Xie, Olga Voznesensky, Prateek Khanna, Carla Calagua, Yang Bai, Justin W. Kung, Jim S. Wu, Eva Corey, Bruce Montgomery, Sandrine Macé, Diego A. Gianolio, Glenn J. Bubley, Steven P. Balk, Paraskevi Giannakakou, Rupal S. Bhatt - Journal of Clinical Investigation 2020 cited by 53
Randomized Phase II Study Evaluating the Addition of Pembrolizumab to Radium-223 in Metastatic Castration-resistant Prostate Cancer
Authors: Atish D. Choudhury, Lucia Kwak, Alexander Cheung, Kathryn M. Allaire, Jaqueline Marquez, David D. Yang, Abhishek Tripathi, Jacqueline M. Kilar, Meredith Flynn, Brianna Maynard, Rebecca Reichel, Amanda F. Pace, Brandon K. Chen, Eliezer M. Van Allen, Kerry L. Kilbridge, Xiao X. Wei, Bradley A. McGregor, Mark M. Pomerantz, Rupal S. Bhatt, Christopher J. Sweeney, Glenn J. Bubley, Heather A. Jacene, Mary‐Ellen Taplin, Franklin W. Huang, Lauren C. Harshman, Lawrence Fong - Cancer Immunology Research 2024 cited by 35
Phase II Multicenter Study of Enzalutamide in Metastatic Castration-Resistant Prostate Cancer to Identify Mechanisms Driving Resistance
Authors: Rana R. McKay, Lucia Kwak, Jett Crowdis, Jamie M. Sperger, Shuang G. Zhao, Wanling Xie, Lillian Werner, Rosina T. Lis, Zhenwei Zhang, Xiao X. Wei, Joshua M. Lang, Eliezer M. Van Allen, Rupal S. Bhatt, Evan Y. Yu, Peter S. Nelson, Glenn J. Bubley, Bruce Montgomery, Mary‐Ellen Taplin - Clinical Cancer Research 2021 cited by 31
Intratumoral De Novo Steroid Synthesis Activates Androgen Receptor in Castration-Resistant Prostate Cancer and Is Upregulated by Treatment with CYP17A1 Inhibitors
Authors: Changmeng Cai, Sen Chen, Patrick Kwok‐Shing Ng, Glenn J. Bubley, Peter S. Nelson, Elahe A. Mostaghel, Brett T. Marck, Alvin M. Matsumoto, Nicholas I. Simon, Hongyun Wang, Shaoyong Chen, Steven P. Balk - Cancer Research 2011 cited by 424
Fatty acid synthase expression defines distinct molecular signatures in prostate cancer.
Authors: Sabrina Rossi, Edgard Graner, Phillip G. Febbo, Lisa J. Weinstein, Nandita Bhattacharya, Tamás Ónody, Glenn J. Bubley, Stephen Balk, Massimo Loda - 2003 cited by 304
Androgen receptor phosphorylation and stabilization in prostate cancer by cyclin-dependent kinase 1
Authors: Shaoyong Chen, Youyuan Xu, Xin Yuan, Glenn J. Bubley, Steven P. Balk - National Academy of Sciences, Proceedings of the National Academy of Sciences 2006 cited by 203
Outcomes of Post-Neoadjuvant Intense Hormone Therapy and Surgery for High Risk Localized Prostate Cancer: Results of a Pooled Analysis of Contemporary Clinical Trials
Authors: Rana R. McKay, Jacob E. Berchuck, Lucia Kwak, Wanling Xie, Rebecca Silver, Glenn J. Bubley, Peter K. Chang, Andrew A. Wagner, Zhenwei Zhang, Adam S. Kibel, Mary‐Ellen Taplin - The Journal of Urology 2021 cited by 54
FORMULA-509: A multicenter randomized trial of post-operative salvage radiotherapy (SRT) and 6 months of GnRH agonist with or without abiraterone acetate/prednisone (AAP) and apalutamide (Apa) post-radical prostatectomy (RP).
Authors: Paul L. Nguyen, Marisa Kollmeier, Dana E. Rathkopf, Karen E. Hoffman, Amado J. Zurita, Daniel E. Spratt, Robert T. Dess, Stanley L. Liauw, Russell Z. Szmulewitz, David J. Einstein, Glenn J. Bubley, James B. Yu, Yi An, Anthony Wong, Felix Y. Feng, Rana R. McKay, Brent S. Rose, Kee‐Young Shin, Adam S. Kibel, Mary‐Ellen Taplin - Journal of Clinical Oncology 2023 cited by 27
The idiopathic hypereosinophilic syndrome
Authors: PF Weller, Glenn J. Bubley - Blood 1994 cited by 943
Loss of IFN-γ Production by Invariant NK T Cells in Advanced Cancer
Authors: Syed Muhammad Tahir, Olivia Cheng, Angela Shaulov, Yasuhiko Koezuka, Glenn J. Bubley, S. Brian Wilson, Steven P. Balk, Mark A. Exley - The Journal of Immunology 2001 cited by 381